Mini-Review: Clinical Features and Management of Granular Corneal Dystrophy Type 2
- PMID: 37336511
- PMCID: PMC10427907
- DOI: 10.3341/kjo.2023.0032
Mini-Review: Clinical Features and Management of Granular Corneal Dystrophy Type 2
Abstract
Granular corneal dystrophy type 2 (GCD2) is an autosomal dominant corneal stromal dystrophy that is caused by p.Arg124His mutation of transforming growth factor β induced (TGFBI) gene. It is characterized by well demarcated granular shaped opacities in central anterior stroma and as the disease progresses, extrusion of the deposits results in ocular pain due to corneal epithelial erosion. Also, diffuse corneal haze which appears late, causes decrease in visual acuity. The prevalence of GCD2 is high in East Asia including Korea. Homozygous patients show a severe phenotype from an early age, and the heterozygote phenotype varies among patients, depending on several types of compound heterozygous TGFBI mutations. In the initial stage, conservative treatments such as artificial tears, antibiotic eye drops, and bandage contact lenses are used to treat corneal erosion. Different surgical methods are used depending on the depth and extent of the stromal deposits. Phototherapeutic keratectomy removes anterior opacities and is advantageous in terms of its applicability and repeatability. For deeper lesions, deep anterior lamellar keratoplasty can be used as the endothelial layer is not always affected. Recurrence following these treatments are reported within a wide range of rates in different studies due to varying definition of recurrence and follow-up period. In patients who have undergone corneal laser vision-correction surgeries such as photorefractive keratectomy, LASEK, or LASIK including SMILE surgery, corneal opacity exacerbates rapidly with severe deterioration of visual acuity. Further investigations on new treatments of GCD2 are necessary.
Keywords: Corneal dystrophy Avellino type; Granular corneal dystrophy type 2; Hereditary corneal dystrophies.
Conflict of interest statement
Figures




Similar articles
-
Unilateral Granular Type 2 Corneal Dystrophy With Exacerbation After LASIK.Cornea. 2024 May 1;43(5):648-651. doi: 10.1097/ICO.0000000000003490. Epub 2024 Feb 1. Cornea. 2024. PMID: 38300218
-
Compound heterozygous mutations in TGFBI cause a severe phenotype of granular corneal dystrophy type 2.Sci Rep. 2021 Mar 26;11(1):6986. doi: 10.1038/s41598-021-86414-9. Sci Rep. 2021. PMID: 33772078 Free PMC article.
-
Heterozygous Avellino corneal dystrophy 9 years after photorefractive keratectomy: natural or laser-induced accelerated course?Cornea. 2009 May;28(4):465-7. doi: 10.1097/ICO.0b013e31818a7df7. Cornea. 2009. PMID: 19411970
-
Stage-related therapy of corneal dystrophies.Dev Ophthalmol. 2011;48:116-153. doi: 10.1159/000324081. Epub 2011 Apr 26. Dev Ophthalmol. 2011. PMID: 21540634 Review.
-
Clinical findings and treatments of granular corneal dystrophy type 2 (avellino corneal dystrophy): a review of the literature.Eye Contact Lens. 2010 Sep;36(5):296-9. doi: 10.1097/ICL.0b013e3181ef0da0. Eye Contact Lens. 2010. PMID: 20724852 Review.
Cited by
-
Distribution and Surgical Treatment of Corneal Dystrophies Over Eight Decades (1945-2024): An Analysis of Histopathologically Confirmed Cases from a German Center.J Epidemiol Glob Health. 2025 Aug 28;15(1):112. doi: 10.1007/s44197-025-00458-y. J Epidemiol Glob Health. 2025. PMID: 40874967 Free PMC article.
-
In Vivo Confocal Microscopy in Avellino Corneal Dystrophy.Cureus. 2024 Aug 20;16(8):e67311. doi: 10.7759/cureus.67311. eCollection 2024 Aug. Cureus. 2024. PMID: 39301332 Free PMC article.
-
A Novel Mouse Model of Granular Corneal Dystrophy Type II Reveals Impaired Autophagy and Recapitulates Human Pathogenesis.Invest Ophthalmol Vis Sci. 2025 Sep 2;66(12):7. doi: 10.1167/iovs.66.12.7. Invest Ophthalmol Vis Sci. 2025. PMID: 40900077 Free PMC article.
References
-
- Aggarwal S, Peck T, Golen J, Karcioglu ZA. Macular corneal dystrophy: a review. Surv Ophthalmol. 2018;63:609–17. - PubMed
-
- Weiss JS, Moller HU, Aldave AJ, et al. IC3D classification of corneal dystrophies: edition 2. Cornea. 2015;34:117–59. - PubMed
-
- Han KE, Kim TI, Chung WS, et al. Clinical findings and treatments of granular corneal dystrophy type 2 (avellino corneal dystrophy): a review of the literature. Eye Contact Lens. 2010;36:296–9. - PubMed
-
- Holland EJ, Daya SM, Stone EM, et al. Avellino corneal dystrophy. Clinical manifestations and natural history. Ophthalmology. 1992;99:1564–8. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous